Multiple sclerosis-associated retrovirus and MS prognosis: an observational study

S Sotgiu1, C Serra, G Mameli

  • 1Institute of Clinical Neurology, University of Sassari, Italy. stesot@hotmail.com

Neurology
|October 9, 2002
PubMed

Insights

The presence of MS-associated retrovirus (MSRV) in cerebrospinal fluid (CSF) may indicate a progressive course for multiple sclerosis (MS). Patients without MSRV showed a stable disease, while those with MSRV experienced worsening symptoms.

Area of Science:

  • Neurovirology
  • Immunology
  • Neurology

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • MS-associated retrovirus (MSRV) is a potential etiological factor in MS.
  • MSRV may possess gliotoxic properties, potentially worsening MS pathology.

Purpose of the Study:

  • To investigate the association between MSRV presence in cerebrospinal fluid (CSF) and the clinical course of MS.
  • To determine if MSRV influences MS disability progression.

Main Methods:

  • Study included 15 treatment-naive MS patients.
  • Patients were categorized into MSRV-negative (MSRV-) and MSRV-positive (MSRV+) groups based on CSF analysis.
  • A mean follow-up period of 3 years was conducted.

Main Results:

  • MSRV- patients exhibited a stable MS disease course over the follow-up period.
  • MSRV+ patients demonstrated a significantly progressive MS course (p = 0.01).
  • This suggests a correlation between MSRV detection and MS progression.

Conclusions:

  • The presence of MSRV in CSF is associated with a more disabling and progressive form of MS.
  • MSRV may play a role in MS pathogenesis and disease worsening.
  • Further research into MSRV's gliotoxic effects in MS is warranted.